Status:
COMPLETED
Evaluation and Support Care Process Within the Care Pathway of Heart Failure Patients
Lead Sponsor:
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Collaborating Sponsors:
French Cardiology Society
Conditions:
Heart Failure Acute
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Acute heart failure current management turns out to be a relative failure considering its elevated economical and human costs and the poor results obtained in terms of disease outcome. Indeed this dis...
Detailed Description
Acute heart failure current management turns out to be a relative failure considering its elevated economical and human costs and the poor results obtained in terms of disease outcome. Indeed this dis...
Eligibility Criteria
Inclusion
- Patient over 18 years old hospitalized for acute heart failure
- Patient able to express his consent before participating in the study, certified by the caregiver if a written consent is not possible
- Patient able to follow protocol procedures, alone or with a caregiver help
- Caregiver consent to participate in the study and assist the patient during its own participation, if caregiver involvement is necessary
- Patient requiring an hospitalisation of at least 24 hours
- Patient covered by social security or equivalent regimen
- Patient having access to a mobile of fixed phone line
Exclusion
- Admission in intensive care or resuscitation unit AND need for inotropic support, vasodilator, or invasive/non-invasive ventilation for the last 24h
- Renal insufficiency with CKD-EPI clearance inferior to 15 ml/min/1.73m2 since admission or dialysis
- Patient planned transfer to a rehabilitation and recuperative care facility (hospital or nursing home)
- Associated disease requiring frequent re-hospitalizations (cancer, dialysis, repeated sessions during planned hospitalizations)
- Associated disease with a high risk of death for the next 6 months
- Chronical respiratory insufficiency requiring daily invasive ventilation or a more than 3L/min permanent oxygen therapy
- Patient suffering from severe dementia defined by a MMSE score ≤ 9
- Person participating in another research testing another care pathway
- Every other reason which, according to investigator, might interfere with study objective assessment
- Person under judicial protection measure (guardianship, curatorship)
- Person deprived of liberty by a judicial or administrative decision
Key Trial Info
Start Date :
June 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 14 2023
Estimated Enrollment :
361 Patients enrolled
Trial Details
Trial ID
NCT04878263
Start Date
June 28 2021
End Date
December 14 2023
Last Update
November 20 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Sainte Anne
Toulon, Var, France, 83000
2
Centre Hospitalier Intercommunal Toulon La Seyne sur Mer
Toulon, Var, France, 83100